Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis

被引：6
|
作者：
Nichols, Derek [1 ]
Boyle, Theresa A. [2 ]
Noyes, David [1 ]
Latin, Kujtim [3 ]
Feygelman, Vladimir [3 ]
Jackson, Isabel [4 ]
Vujaskovic, Zeljko [4 ]
Antonia, Scott [1 ,5 ]
Perez, Bradford A. [1 ,2 ,3 ,5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA
[4] Univ Maryland, Div Translat Radiat Sci, Dept Radiat Oncol, Sch Med, Baltimore, MD 21202 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 11期
关键词：
CELL LUNG-CANCER; NIVOLUMAB; SAFETY; PEMBROLIZUMAB; CHEMORADIATION; RADIOTHERAPY; CARBOPLATIN; IRRADIATION; IPILIMUMAB; CONCURRENT;
D O I：
10.21037/jtd.2018.10.01
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：6254 / +
页数：8
相关论文
共 50 条
  • [31] Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
    Boustani, Jihane
    Lecoester, Benoit
    Baude, Jeremy
    Latour, Charlene
    Adotevi, Olivier
    Mirjolet, Celine
    Truc, Gilles
    CANCERS, 2021, 13 (19)
  • [32] Anti-PD-1 monotherapy outperforms multiple immunotherapy combination strategies in an oral cancer prevention mouse model
    Novaes, Jose Augusto Monteiro de Oliveira
    Pisegna, Marlese A.
    Poteete, Alissa
    Zhang, Fahao
    Heymach, John V.
    William, William N.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
    Gide, Tuba N.
    Quek, Camelia
    Menzies, Alexander M.
    Tasker, Annie T.
    Shang, Ping
    Holst, Jeff
    Madore, Jason
    Lim, Su Yin
    Velickovic, Rebecca
    Wongchenko, Matthew
    Yan, Yibing
    Lo, Serigne
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Pang, Angel
    McGuire, Helen M.
    Palendira, Umaimainthan
    Thompson, John F.
    Rizos, Helen
    da Silva, Ines Pires
    Batten, Marcel
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    CANCER CELL, 2019, 35 (02) : 238 - +
  • [34] Safety and Activity of Combined Radiation Therapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) With Metastatic Melanoma
    Liniker, E.
    Kong, B.
    Menzies, A. M.
    Cooper, A. J.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Carlino, M. S.
    Wang, T. W.
    Long, G. V.
    Hong, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E635 - E635
  • [35] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [36] Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
    Mitchell, Dana
    Dey, Mahua
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S577 - S579
  • [37] Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
    Hughes, Jing
    Vudattu, Nalini
    Sznol, Mario
    Gettinger, Scott
    Kluger, Harriet
    Lupsa, Beatrice
    Herold, Kevan C.
    DIABETES CARE, 2015, 38 (04) : e55 - e57
  • [38] Precipitation of type 1 diabetes with anti-PD-1 immunotherapy
    Hussein, Ahmed
    Duke, Anna
    McLean, Mark
    Hng, Tien-Ming
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 90 - 90
  • [39] Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy
    Cao, Yiyi
    Li, Wenbo
    Wang, ZhengJie
    Pang, Hua
    TUMORI JOURNAL, 2021, 107 (04): : 282 - 291
  • [40] Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
    Kong, Yuehong
    Ma, Yifu
    Zhao, Xiangrong
    Pan, Jie
    Xu, Zhi
    Zhang, Liyuan
    FRONTIERS IN ONCOLOGY, 2021, 11
12345